<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01647581</url>
  </required_header>
  <id_info>
    <org_study_id>CLNB-005-13F</org_study_id>
    <secondary_id>DVAMC-11-026</secondary_id>
    <nct_id>NCT01647581</nct_id>
  </id_info>
  <brief_title>Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping</brief_title>
  <official_title>Risk of Post-Polypectomy Bleeding With Prophylactic Hemoclipping</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized trial aimed at determining whether or not hemoclips are effective in preventing
      post-polypectomy bleeds on polyps that are 10mm in size or greater.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2011</start_date>
  <completion_date type="Actual">November 1, 2018</completion_date>
  <primary_completion_date type="Actual">November 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Delayed Post Polypectomy Bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>rectal bleeding with associated Hb 2g drop, hemodynamic instability, or need for repeat colonoscopy or angiography or surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11182</enrollment>
  <condition>Post-polypectomy Bleeding</condition>
  <condition>Polypectomy</condition>
  <condition>Elective Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Clip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A clip is been placed at the polypectomy site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Clip</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A hemoclip is not placed at the site of the polypectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemoclip Placement</intervention_name>
    <description>Placement of hemoclip at polypectomy site for polyps at least 1cm in size</description>
    <arm_group_label>Clip</arm_group_label>
    <other_name>Clip</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NO hemoclip placement</intervention_name>
    <description>No hemoclip placement (placebo / sham)</description>
    <arm_group_label>No Clip</arm_group_label>
    <other_name>No Clip</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for elective colonoscopy

        Exclusion Criteria:

          -  Patients in which polypectomy can not be performed safely
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Linda A Feagins</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Texas Health Care System, San Antonio, TX</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Veterans Health Care System, Temple, TX</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 19, 2012</study_first_submitted>
  <study_first_submitted_qc>July 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2012</study_first_posted>
  <results_first_submitted>August 9, 2019</results_first_submitted>
  <results_first_submitted_qc>September 24, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 15, 2019</results_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemoclip</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>post-polypectomy bleed</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
    <mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
    <mesh_term>beta-Endorphin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT01647581/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>11,182 enrolled into the study, but 10,084 screen failures as the majority did not have a polyp 1cm in size to meet criteria for randomization</recruitment_details>
      <pre_assignment_details>Must have polyp 1cm in size removed during colonoscopy</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Clip</title>
          <description>A clip is been placed at the polypectomy site.
Hemoclip Placement: Placement of hemoclip at polypectomy site for polyps at least 1cm in size</description>
        </group>
        <group group_id="P2">
          <title>No Clip</title>
          <description>A hemoclip is not placed at the site of the polypectomy.
NO hemoclip placement: No hemoclip placement (placebo / sham)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="547"/>
                <participants group_id="P2" count="551"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="530"/>
                <participants group_id="P2" count="520"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Clip</title>
          <description>A clip is been placed at the polypectomy site.
Hemoclip Placement: Placement of hemoclip at polypectomy site for polyps at least 1cm in size</description>
        </group>
        <group group_id="B2">
          <title>No Clip</title>
          <description>A hemoclip is not placed at the site of the polypectomy.
NO hemoclip placement: No hemoclip placement (placebo / sham)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="530"/>
            <count group_id="B2" value="520"/>
            <count group_id="B3" value="1050"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="251"/>
                    <measurement group_id="B2" value="246"/>
                    <measurement group_id="B3" value="497"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="279"/>
                    <measurement group_id="B2" value="274"/>
                    <measurement group_id="B3" value="553"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.5" spread="7.9"/>
                    <measurement group_id="B2" value="64.0" spread="8.6"/>
                    <measurement group_id="B3" value="64.3" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="516"/>
                    <measurement group_id="B2" value="499"/>
                    <measurement group_id="B3" value="1015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>white</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="370"/>
                    <measurement group_id="B2" value="375"/>
                    <measurement group_id="B3" value="745"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="530"/>
                    <measurement group_id="B2" value="520"/>
                    <measurement group_id="B3" value="1050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>smoking</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="197"/>
                    <measurement group_id="B2" value="190"/>
                    <measurement group_id="B3" value="387"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Delayed Post Polypectomy Bleeding</title>
        <description>rectal bleeding with associated Hb 2g drop, hemodynamic instability, or need for repeat colonoscopy or angiography or surgery</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Clip</title>
            <description>A clip is been placed at the polypectomy site.
Hemoclip Placement: Placement of hemoclip at polypectomy site for polyps at least 1cm in size</description>
          </group>
          <group group_id="O2">
            <title>No Clip</title>
            <description>A hemoclip is not placed at the site of the polypectomy.
NO hemoclip placement: No hemoclip placement (placebo / sham)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Delayed Post Polypectomy Bleeding</title>
          <description>rectal bleeding with associated Hb 2g drop, hemodynamic instability, or need for repeat colonoscopy or angiography or surgery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="530"/>
                <count group_id="O2" value="520"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Clip</title>
          <description>A clip is been placed at the polypectomy site.
Hemoclip Placement: Placement of hemoclip at polypectomy site for polyps at least 1cm in size</description>
        </group>
        <group group_id="E2">
          <title>No Clip</title>
          <description>A hemoclip is not placed at the site of the polypectomy.
NO hemoclip placement: No hemoclip placement (placebo / sham)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain / bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Rectal absess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Unimportant bleed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gallstones</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Post-polypectomy bleed</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Post-polypectomy coagulation syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory illnesses and diseases</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Elective laminectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebrovascular accident / Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Unimportant bleed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
              <event>
                <sub_title>Rectal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Multiple falls</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="547"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="551"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Linda Feagins</name_or_title>
      <organization>VA</organization>
      <phone>214-587-1603</phone>
      <email>linda.feagins@austin.utexas.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

